Skip to main content
. 2021 Feb 25;47(4):63. doi: 10.3892/ijmm.2021.4896

Figure 1.

Figure 1

SS31 treatment attenuates DOX-induced inhibition of H9c2 cell survival. (A) The cell viability was determined in H9c2 cells. (B) LDH release level was measured in H9c2 cells supernatant. (C and D) Crystal violet staining and quantitative analysis of living cells. Magnification, ×200. **P<0.01 and ***P<0.001 vs. control; #P<0.05 and ##P<0.01 vs. DOX; ns, not statistically significant. DOX, doxorubicin; SS31, Szeto-Schiller 31 peptide; LDH, lactate dehydrogenase; OD, optical density.